Analysts are looking for high single-digit earnings growth over the next couple years, and the company also began paying a dividend in 2010.
Although the stock risen with the overall market since September 1, shares are still reasonably priced with a PEG ratio of 1.2.
Company Description
Patterson Companies, Inc. distributes various equipment and supplies to the dental, companion-pet veterinarian and rehabilitation markets. The company was founded in 1877 and is headquartered in St. Paul, Minnesota.
It has a market cap of $4.1 billion.
Second Quarter EPS In-Line
Patterson reported second quarter 2011 earnings per share of 45 cents, in-line with the Zacks Consensus Estimate. It was an 8% increase year-over-year.
Total sales were up 5% over the same quarter last year. The Dental Supply division was also up 5%, driven by a 14% increase in dental equipment and software. Revenues from the Webster Veterinary segment were up slightly.
Meanwhile, the gross margin declined slightly from 32.7% to 32.6% of sales, while the operating margin improved slightly from 10.4% to 10.5%.
Outlook
Estimates have been moving higher recently following one analyst's upgrade. Based on a proprietary survey, he believes that patient volumes will accelerate in 2011 and 2012, thus boosting dental equipment purchases.
The Zacks Consensus Estimate for 2011 is $1.95, representing 9% growth over 2010 EPS. This falls within management's guidance of $1.89 to $1.99 per share.
The consensus estimate for 2012 is currently $2.13, corresponding to 9% growth. It is a Zacks #2 Rank (Buy).
Fundamentals
The stock has risen more than 30% since late August.
Shares are trading at 17.0x forward earnings, a discount to the industry average of 19.4x. It sports a PEG ratio of 1.2.
Its price to book ratio of 2.7 is in-line with its peers.
Patterson began paying a dividend in 2010. It currently yields 1.3%.
Todd Bunton is the Growth & Income Stock Strategist for Zacks.com.
PATTERSON COS (PDCO): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.